Exane Derivatives’s British American Tobacco BTI Stock Holding History
Bought
Maintained
Sold
Other funds holding BTI
OAG
Exane Derivatives's BTI Position: Q2 2022 in Review
Exane Derivatives sold out of British American Tobacco (BTI) in Q2 2022, closing a stake of 6,189 shares — an estimated $261K sold.
Exane Derivatives first reported a position in BTI in Q1 2022 and held it in 1 quarter. The position peaked at $261K in Q1 2022. 573 funds tracked by Wall St. Rank hold BTI as of Q2 2022.
- Exane Derivatives reported no remaining British American Tobacco position as of Q2 2022 after selling out during the quarter.
- Exane Derivatives sold 6,189 British American Tobacco shares in Q2 2022, an estimated $261K.
- Exane Derivatives first reported a position in British American Tobacco in Q1 2022 and held it in 1 quarter.
- Exane Derivatives's British American Tobacco position peaked at $261K in Q1 2022.
- 573 funds tracked by Wall St. Rank held British American Tobacco as of Q2 2022.
Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.